Your browser doesn't support javascript.
loading
Cost-effectiveness of adding oseltamivir to primary care for influenza-like-illness: economic evaluation alongside the randomised controlled ALIC4E trial in 15 European countries.
Li, Xiao; Bilcke, Joke; van der Velden, Alike W; Bruyndonckx, Robin; Coenen, Samuel; Bongard, Emily; de Paor, Muirrean; Chlabicz, Slawomir; Godycki-Cwirko, Maciek; Francis, Nick; Aabenhus, Rune; Bucher, Heiner C; Colliers, Annelies; De Sutter, An; Garcia-Sangenis, Ana; Glinz, Dominik; Harbin, Nicolay J; Kosiek, Katarzyna; Lindbæk, Morten; Lionis, Christos; Llor, Carl; Mikó-Pauer, Réka; Radzeviciene Jurgute, Ruta; Seifert, Bohumil; Sundvall, Pär-Daniel; Touboul Lundgren, Pia; Tsakountakis, Nikolaos; Verheij, Theo J; Goossens, Herman; Butler, Christopher C; Beutels, Philippe.
Afiliação
  • Li X; Centre for Health Economics Research and Modelling Infectious Diseases (CHERMID), Vaccine and Infectious Disease Institute (VAXINFECTIO), University of Antwerp, Campus Drie Eiken, room D.S.221, Universiteitsplein 1, 2610, Antwerp, Belgium. xiao.li@uantwerpen.be.
  • Bilcke J; Centre for Health Economics Research and Modelling Infectious Diseases (CHERMID), Vaccine and Infectious Disease Institute (VAXINFECTIO), University of Antwerp, Campus Drie Eiken, room D.S.221, Universiteitsplein 1, 2610, Antwerp, Belgium.
  • van der Velden AW; Julius Center for Health Sciences and Primary Care, University Medical Center, Utrecht, The Netherlands.
  • Bruyndonckx R; Interuniversity Institute for Biostatistics and Statistical Bioinformatics (I-BIOSTAT), Data Science Institute (DSI), Hasselt University, Hasselt, Belgium.
  • Coenen S; Laboratory of Medical Microbiology, Vaccine and Infectious Disease Institute (VAXINFECTIO), University of Antwerp, Antwerp, Belgium.
  • Bongard E; Laboratory of Medical Microbiology, Vaccine and Infectious Disease Institute (VAXINFECTIO), University of Antwerp, Antwerp, Belgium.
  • de Paor M; Department of Family Medicine and Population Health (FAMPOP), University of Antwerp, Antwerp, Belgium.
  • Chlabicz S; The Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.
  • Godycki-Cwirko M; RCSI Department of General Practice, 123 St Stephens Green, Dublin 2, Ireland.
  • Francis N; Department of Family Medicine, Medical University of Bialystok, Bialystok, Poland.
  • Aabenhus R; Centre for Family and Community Medicine, Medical University of Lodz, Lodz, Poland.
  • Bucher HC; School of Primary Care, Population Sciences and Medical Education, Faculty of Medicine, University of Southampton, Southampton, UK.
  • Colliers A; Section and Research Unit of General Practice, Department of Public Health, University of Copenhagen, Copenhagen, Denmark.
  • De Sutter A; Division of Infectious Diseases and Hospital Hygiene, Basel Institute for Clinical Epidemiology and Biostatistics, University Hospital Basel, Basel, Switzerland.
  • Garcia-Sangenis A; Department of Family Medicine and Population Health (FAMPOP), University of Antwerp, Antwerp, Belgium.
  • Glinz D; Department of Public Health and Primary Care (Centre for Family Medicine), Gent University, Gent, Belgium.
  • Harbin NJ; University Institute in Primary Care Research Jordi Gol, Via Roma Health Centre, Barcelona, Spain.
  • Kosiek K; Department of Clinical Research, Basel Institute for Clinical Epidemiology and Biostatistics, University Hospital Basel, Basel, Switzerland.
  • Lindbæk M; Department of General Practice, Antibiotic Center for Primary Care, Institute of Health and Society, University of Oslo, Oslo, Norway.
  • Lionis C; Family Doctors' Clinic, Lodz, Poland.
  • Llor C; Research Leader Antibiotic Centre for Primary Care, Department of General Practice, University of Oslo, Oslo, Norway.
  • Mikó-Pauer R; General Practice and Primary Health Care at the School of Medicine, University of Crete, Crete, Greece.
  • Radzeviciene Jurgute R; University Institute in Primary Care Research Jordi Gol, Via Roma Health Centre, Barcelona, Spain.
  • Seifert B; Research Unit for General Practice, Department of Public Health, University of Copenhagen, Copenhagen, Denmark.
  • Sundvall PD; DRC Drug Research Center LLC, Balatonfüred, Hungary.
  • Touboul Lundgren P; FDC Mano seimos gydytojas, Klaipeda, Lithuania.
  • Tsakountakis N; Institute of General Practice, First Faculty of Medicine, Charles University in Prague, Prague, Czech Republic.
  • Verheij TJ; General Practice/Family Medicine, School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
  • Goossens H; Research, Education, Development and Innovation, Primary Health Care, Region Västra Götaland, Sandared, Sweden.
  • Butler CC; Département de Santé Publique, Hôpital de l'Archet, Nice, France.
  • Beutels P; Malia Surgery, Kastelli HC, Heraklio, Greece.
Eur J Health Econ ; 24(6): 909-922, 2023 Aug.
Article em En | MEDLINE | ID: mdl-36131214
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Viroses / Influenza Humana Tipo de estudo: Clinical_trials / Health_economic_evaluation Limite: Adolescent / Adult / Child / Humans País/Região como assunto: Europa Idioma: En Revista: Eur J Health Econ Assunto da revista: SAUDE PUBLICA / SERVICOS DE SAUDE Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Bélgica
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Viroses / Influenza Humana Tipo de estudo: Clinical_trials / Health_economic_evaluation Limite: Adolescent / Adult / Child / Humans País/Região como assunto: Europa Idioma: En Revista: Eur J Health Econ Assunto da revista: SAUDE PUBLICA / SERVICOS DE SAUDE Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Bélgica